Retinopathy of Prematurity Ophthalmologic Approach Medication

1. Fevereiro-Martins M, Marques-Neves C, Guimarães H, Bicho M. Retinopathy of prematurity: A review of pathophysiology and signaling pathways. Surv Ophthalmol. 2023 Mar-Apr. 68 (2):175-210. [QxMD MEDLINE Link].

2. International Committee for the Classification of Retinopathy of Prematurity. The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005 Jul. 123 (7):991-9. [QxMD MEDLINE Link].

3. Chiang MF, Quinn GE, Fielder AR, Ostmo SR, Paul Chan RV, Berrocal A, et al. International Classification of Retinopathy of Prematurity, Third Edition. Ophthalmology. 2021 Oct. 128 (10):e51-e68. [QxMD MEDLINE Link]. [Full Text].

4. Tsai, A.S.H., Acaba-Berrocal, L., Sobhy, M. et al. Current Management of Retinopathy of Prematurity. Curr Treat Options Peds. 2022. 8:246-261.

5. American Academy of Pediatrics Section on Ophthalmology; American Academy of Ophthalmology; American Association for Pediatric Ophthalmology and Strabismus; American Association of Certified Orthoptists. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2013 Jan. 131(1):189-95. [QxMD MEDLINE Link]. [Full Text].

6. Terry TL. Extreme prematurity and fibroplastic overgrowth of persistent vascular sheath behind each crystalline lens I. Preliminary report. Am J Ophthalmol. 1942. 25:203-4.

7. Campbell K. Intensive oxygen therapy as a possible cause for retrolental fibroplasia. A clinical approach. Med J Austr. 1951. 2:48-50.

8. Kretzer FL, Hittner HM. Retinopathy of prematurity: clinical implications of retinal development. Arch Dis Child. 1988 Oct. 63(10 Spec No):1151-67. [QxMD MEDLINE Link].

9. Ashton N. Oxygen and the retinal blood vessels. Trans Ophthalmol Soc U K. 1980 Sep. 100(3):359-62. [QxMD MEDLINE Link].

10. Csak K, Szabo V, Szabo A, et al. Pathogenesis and genetic basis for retinopathy of prematurity. Front Biosci. 2006 Jan 1. 11:908-20. [QxMD MEDLINE Link].

11. Fielder AR, Shaw DE, Robinson J, et al. Natural history of retinopathy of prematurity: a prospective study. Eye. 1992. 6 (Pt 3):233-42. [QxMD MEDLINE Link].

12. Varughese S, Gilbert C, Pieper C, et al. Retinopathy of prematurity in South Africa: an assessment of needs, resources and requirements for screening programmes. Br J Ophthalmol. 2008 Jul. 92(7):879-82. [QxMD MEDLINE Link].

13. Palmer EA, Flynn JT, Hardy RJ, et al. Incidence and early course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1991 Nov. 98(11):1628-40. [QxMD MEDLINE Link].

14. Wallace DK, Freedman SF, Hartnett ME, Quinn GE. Predictive Value of Pre-plus Disease in Retinopathy of Prematurity. Arch Ophthalmol. 2011 May. 129(5):591-6. [QxMD MEDLINE Link].

15. Tolsma KW, Allred EN, Chen ML, et al. Neonatal bacteremia and retinopathy of prematurity: the ELGAN study. Arch Ophthalmol. 2011 Dec. 129(12):1555-63. [QxMD MEDLINE Link].

16. Melville N. Fluorescein Angiography Details Vasculature in ROP. Medscape Medical News. Available at http://www.medscape.com/viewarticle/823289. Accessed: April 14, 2014.

17. American Association for Pediatric Ophthalmology and Strabismus (AAPOS) 2014: Abstract 10. Presented April 3, 2014.

18. Lajoie A, Koreen S, Wang L, et al. Retinopathy of prematurity management using single-image vs multiple-image telemedicine examinations. Am J Ophthalmol. 2008 Aug. 146(2):298-309. [QxMD MEDLINE Link].

19. Geloneck MM, Chuang AZ, Clark WL, et al, for the BEAT-ROP Cooperative Group. Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial. JAMA Ophthalmol. 2014 Aug 7. [QxMD MEDLINE Link].

20. Boggs W. Lower risk of very high myopia with vevacizumab for retinopathy of prematurity. Reuters Health Information. August 14, 2014. [Full Text].

21. Roach L. Laser treatment halts retinopathy in extreme prematurity. Medscape Medical News. April 4, 2013. [Full Text].

22. Gunn DJ, Cartwright DW, Yuen SA, Gole GA. Treatment of retinopathy of prematurity in extremely premature infants over an 18-year period. Clin Experiment Ophthalmol. 2013 Mar. 41(2):159-66. [QxMD MEDLINE Link].

23. Harrison P. Lens Clarity Excellent With Vitrectomy in Early Retinopathy. Medscape Medical News. Available at http://www.medscape.com/viewarticle/810151. Accessed: September 11, 2013.

24. Dempsey E, McCreery K. Local anaesthetic eye drops for prevention of pain in preterm infants undergoing screening for retinopathy of prematurity. Cochrane Database Syst Rev. 2011 Sep 7. 9:CD007645. [QxMD MEDLINE Link].

25. Repka MX, Hardy RJ, Phelps DL, et al. Surfactant prophylaxis and retinopathy of prematurity. Arch Ophthalmol. 1993 May. 111(5):618-20. [QxMD MEDLINE Link].

26. Wu WC, Yeh PT, Chen SN, Yang CM, Lai CC, Kuo HK. Effects and complications of bevacizumab use in patients with retinopathy of prematurity: a multicenter study in taiwan. Ophthalmology. 2011 Jan. 118(1):176-83. [QxMD MEDLINE Link].

27. Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011 Feb 17. 364(7):603-15. [QxMD MEDLINE Link].

28. Chang E, Josan AS, Purohit R, Patel CK, Xue K. A Network Meta-Analysis of Retreatment Rates following Bevacizumab, Ranibizumab, Aflibercept, and Laser for Retinopathy of Prematurity. Ophthalmology. 2022 Dec. 129 (12):1389-1401. [QxMD MEDLINE Link].

29. Cryotherapy for Retinopathy of Prematurity Cooperative Group. Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome--structure and function. Arch Ophthalmol. 1990 Oct. 108(10):1408-16. [QxMD MEDLINE Link].

30. Early Treatment For Retinopathy Of Prematurity Cooperative Group. Revised indications for the treatment of retinopathy of prematurity: results of the early treatment for retinopathy of prematurity randomized trial. Arch Ophthalmol. 2003 Dec. 121(12):1684-94. [QxMD MEDLINE Link].

31. Laser ROP Study Group. Laser therapy for retinopathy of prematurity. Arch Ophthalmol. 1994 Feb. 112(2):154-6. [QxMD MEDLINE Link].

32. Phelps DL. Retinopathy of prematurity: an estimate of vision loss in the United States--1979. Pediatrics. 1981 Jun. 67(6):924-5. [QxMD MEDLINE Link].

33. Repka MX, Tung B, Good WV, et al. Outcome of eyes developing retinal detachment during the Early Treatment for Retinopathy of Prematurity Study (ETROP). Arch Ophthalmol. 2006 Jan. 124(1):24-30. [QxMD MEDLINE Link].

34. Reynolds JD, Hardy RJ, Kennedy KA, et al. Lack of efficacy of light reduction in preventing retinopathy of prematurity. Light Reduction in Retinopathy of Prematurity (LIGHT-ROP) Cooperative Group. N Engl J Med. 1998 May 28. 338(22):1572-6. [QxMD MEDLINE Link].

35. Schaffer DB, Palmer EA, Plotsky DF, et al. Prognostic factors in the natural course of retinopathy of prematurity. The Cryotherapy for Retinopathy of Prematurity Cooperative Group. Ophthalmology. 1993 Feb. 100(2):230-7. [QxMD MEDLINE Link].

36. Section on Ophthalmology American Academy of Pediatrics, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2006 Feb. 117(2):572-6. [QxMD MEDLINE Link].

37. Supplemental Therapeutic Oxygen for Prethreshold Retinopathy Of Prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000 Feb. 105(2):295-310. [QxMD MEDLINE Link].

38. The Committee for the Classification of Retinopathy of Prematurity. An international classification of retinopathy of prematurity. Arch Ophthalmol. 1984 Aug. 102(8):1130-4. [QxMD MEDLINE Link].

39. Fang JL, Sorita A, Carey WA, Colby CE, Murad MH, Alahdab F. Interventions To Prevent Retinopathy of Prematurity: A Meta-analysis. Pediatrics. 2016 Mar 9. [QxMD MEDLINE Link].

40. Eldweik L, Mantagos IS. Role of VEGF Inhibition in the Treatment of Retinopathy of Prematurity. Semin Ophthalmol. 2016. 31 (1-2):163-8. [QxMD MEDLINE Link].

41. Cao JH, Wagner BD, McCourt EA, Cerda A, Sillau S, Palestine A, et al. The Colorado-retinopathy of prematurity model (CO-ROP): postnatal weight gain screening algorithm. J AAPOS. 2016 Feb. 20 (1):19-24. [QxMD MEDLINE Link].

42. Shah PK, Prabhu V, Karandikar SS, Ranjan R, Narendran V, Kalpana N. Retinopathy of prematurity: Past, present and future. World J Clin Pediatr. 2016 Feb 8. 5 (1):35-46. [QxMD MEDLINE Link]. [Full Text].

Mounir Bashour, MD, PhD, CM, FRCSC, FACS Assistant Professor of Ophthalmology, McGill University Faculty of Medicine; Clinical Assistant Professor of Ophthalmology, Sherbrooke University; Medical Director, Cornea Laser and Lasik MD

Mounir Bashour, MD, PhD, CM, FRCSC, FACS is a member of the following medical societies: American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American College of International Physicians, American College of Surgeons, American Medical Association, American Society of Cataract and Refractive Surgery, American Society of Mechanical Engineers, American Society of Ophthalmic Plastic and Reconstructive Surgery, Biomedical Engineering Society, Canadian Medical Association, Canadian Ophthalmological Society, Contact Lens Association of Ophthalmologists, International College of Surgeons US Section, Ontario Medical Association, Quebec Medical Association, Royal College of Physicians and Surgeons of Canada

Disclosure: Nothing to disclose.

Johanne Menassa, MD Staff Physician, Department of Ophthalmology, University of Laval Hospital, Quebec City

Disclosure: Nothing to disclose.

C Corina Gerontis, MD Consulting Staff, Departments of Pediatrics and Ophthalmology, Schneider Children's Hospital/Long Island Jewish Medical Center

C Corina Gerontis, MD is a member of the following medical societies: Alpha Omega Alpha, American Academy of Ophthalmology, American Association for Pediatric Ophthalmology and Strabismus, American Medical Association

Disclosure: Nothing to disclose.

Simon K Law, MD, PharmD Clinical Professor of Health Sciences, Department of Ophthalmology, Jules Stein Eye Institute, University of California, Los Angeles, David Geffen School of Medicine

Simon K Law, MD, PharmD is a member of the following medical societies: American Academy of Ophthalmology, Association for Research in Vision and Ophthalmology, American Glaucoma Society

Disclosure: Nothing to disclose.

Steve Charles, MD Founder and CEO of Charles Retina Institute; Clinical Professor, Department of Ophthalmology, University of Tennessee College of Medicine

Disclosure: Received royalty and consulting fees for: Alcon Laboratories.

Donny W Suh, MD, MBA, FAAP, FACS Professor, Department of Ophthalmology, Chief of Pediatric Ophthalmology and Adult Strabismus, Medical Director of Eye-Mobile, Gavin Herbert Eye Institute, UC Irvine Health, University of California, Irvine, School of Medicine; Associate Clinical Professor, Department of Pediatrics, Creighton University School of Medicine; Chief Medical Officer, Suh Precision Syringe, LLC; Medical Staff, Children’s Hospital of Orange County

Donny W Suh, MD, MBA, FAAP, FACS is a member of the following medical societies: American Academy of Ophthalmology, American Academy of Pediatrics, American Association for Pediatric Ophthalmology and Strabismus, American College of Healthcare Executives, American College of Surgeons, American Medical Association, Section on Ophthalmology, American Ophthalmological Society, International Strabismological Association, Iowa Medical Society, Metro Omaha Medical Society, National Eye Care Project, Nebraska Chapter of American Academy of Pediatrics, ORBIS, Surgical Eye Expeditions (SEE) International

Disclosure: Nothing to disclose.

V Al Pakalnis, MD, PhD Professor of Ophthalmology, University of South Carolina School of Medicine; Chief of Ophthalmology, Dorn Veterans Affairs Medical Center

V Al Pakalnis, MD, PhD is a member of the following medical societies: American Academy of Ophthalmology, American College of Surgeons, South Carolina Medical Association

Disclosure: Nothing to disclose.

• Print this section
• Print the entire contents of
• Print the entire contents of article